OpenVSafe by OpenVAERS
Search V-safe

4N8-58192-86927

3 vaccinations 3 coded responses 19 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
436 / OH
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness, Abdominal pain
    Adult check-in
  4. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  5. 2021-01-13
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache, Nausea
    Adult check-in
  6. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work
    Adult check-in
  7. 2021-01-14
  8. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  9. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  11. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  12. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  13. 2021-01-20
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  14. 2021-01-29
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-05
    Survey response — day 21, dose 2
    MedDRA: Menstrual disorder — Feeling: Good
    Free text: Menstrual issues that are abnormal since the vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-10
    Survey response — day 28, dose 2
    MedDRA: Intermenstrual bleeding — Feeling: Fair
    Free text: Following the second Pfizer vaccine, I had abnormal spotting that was almost a second period in the middle of my cycle
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-17
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-02-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-16
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-14
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  21. 2021-11-18
    Dose 3 — Pfizer-BioNTech
  22. 2022-01-13
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in
  23. 2022-05-19
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  24. 2022-11-18
    Survey response — 12 months, dose 3
    MedDRA: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea, Headache, Myalgia, Nasal congestion, Respiratory tract congestion, SARS-CoV-2 test positive, Sinus congestion, Sneezing, Vomiting, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: I contracted COVID-19. Symptoms developed on 11/2. I tested positive on 11/7. Symptoms included cough, congestion, wheezing, headache, muscle aches, vomiting and diarrhea, sneezing, nasal and sinus congestion, and loss of smell and taste.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-11-18
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  26. 2022-11-21

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-13Pfizer-BioNTech
32021-11-18Pfizer-BioNTech No

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 3 — day 21, dose 2

2021-02-05

Symptoms: Menstrual issues that are abnormal since the vaccine

Release 3 — day 28, dose 2

2021-02-10

Symptoms: Following the second Pfizer vaccine, I had abnormal spotting that was almost a second period in the middle of my cycle

Release 12 — 12 months, dose 3

2022-11-18

Symptoms: I contracted COVID-19. Symptoms developed on 11/2. I tested positive on 11/7. Symptoms included cough, congestion, wheezing, headache, muscle aches, vomiting and diarrhea, sneezing, nasal and sinus congestion, and loss of smell and taste.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDAnosmia · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea · · ✓
SDHeadache · · ✓
SDIntermenstrual bleeding ✓ ✓ ✓
SDMenstrual disorder ✓ ✓ ✓
SDMyalgia · · ✓
SDNasal congestion · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSinus congestion · · ✓
SDSneezing · · ✓
SDVomiting · · ✓
SDWheezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release